Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Japanese Rapist Gets First-Ever Caning Sentence: 17 Years in Prison and 20 Strokes in Singapore

inews24 Views  

A Japanese man who raped a female university student in Singapore has been sentenced to 17 years and 6 months in prison and 20 strokes of the cane.

Pixabay

According to Asahi TV News, a 38-year-old Japanese hairdresser who was sentenced to 17 years and 6 months in prison and 20 strokes of the cane by a Singapore court for raping a female university student on August 1 has decided not to appeal.

The hairdresser is the first Japanese national to receive a caning sentence.

The defense lawyer, Takehiro Miyoshi, told Asahi TV, “We decided not to appeal, as there is little chance of a significant reduction in the sentence.”

In Singapore, caning is permitted for male offenders between the ages of 16 and 50, both locals and foreigners, for crimes such as drug trafficking, rape, fraud, corruption, and robbery.

The convicted individual is required to change into clothing that exposes the buttocks, after which they are struck on the back of the thighs with a 1.5-meter-long and 1.27-centimeter-thick rattan cane.

Typically, caning is carried out in one session on a single day, but the exact date of the hairdresser’s caning has not been disclosed.

It is said that the individual is notified of the execution of the caning on the day it is carried out.

Singapore’s caning is notorious for being severe.

Attorney Miyoshi reported, “According to accounts from those who have actually experienced caning, they cannot sleep on their back for 1-2 months after the punishment.”

inews24
content@viewusglobal.com

Comments0

300

Comments0

[ASIA] Latest Stories

  • North Korea Buried in April Snow—Experts Warn of Major Crop Damage After Climate Shock
  • North Korea’s Smartest Teens Are Being Dragged Into the Military—Here’s Why
  • North Korea Opens Its First Internet Café—and Kim Jong Un Brings His Daughter
  • Vietnam Cracks Down on Imports to Avoid U.S. Tariff Backlash
  • Hyundai Ioniq 5 N Time Spec Breaks Tsukuba Circuit Record, Cementing EV Performance Legacy
  • North Korea Sends Young Volunteers to Dangerous Jobs Under the Guise of Voluntary Participation

You May Also Like

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE&nbsp

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE&nbsp

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE&nbsp

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE&nbsp

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE&nbsp

Must-Reads

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE